{{Rsnum
|rsid=4585
|Gene=ATM
|Chromosome=11
|position=108368901
|Orientation=plus
|GMAF=0.4793
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ATM,C11orf65
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 18.6 | 54.0 | 27.4
| HCB | 32.6 | 45.9 | 21.5
| JPT | 34.9 | 43.1 | 22.0
| YRI | 28.2 | 59.2 | 12.7
| ASW | 31.5 | 40.7 | 27.8
| CHB | 32.6 | 45.9 | 21.5
| CHD | 28.7 | 50.9 | 20.4
| GIH | 10.2 | 37.8 | 52.0
| LWK | 48.1 | 41.5 | 10.4
| MEX | 17.5 | 43.9 | 38.6
| MKK | 47.4 | 40.8 | 11.8
| TSI | 13.0 | 33.0 | 54.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21058196
|Title=Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk
}}

[[Metformin Response]]

{{PMID Auto
|PMID=25196645
|Title=Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}